FGFR

CAT # Product Name Tsanangudzo
CPD100464 Erdafitinib Erdafitinib, inozivikanwawo seJNJ-42756493, ine simba uye inosarudza nemuromo bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor ine inogona kuita antineoplastic chiitiko. Pamusoro pekutonga nemuromo, JNJ-42756493 inosungira uye inhibits FGFR, iyo inogona kukonzera kuvharwa kweFGFR-yakabatana nechiratidzo chekushandura nzira uye nokudaro kuvharidzirwa kwekuputika kwemasero ekuputika uye kufa kwechirwere chechirwere muFGFR-overexpressing tumor cells. FGFR, yakasimudzwa mune akawanda tumor cell marudzi, ndeye receptor tyrosine kinase yakakosha ku tumor cell kuwanda, kusiyanisa uye kurarama.
CPD3618 TAS-120 TAS-120 ndeyemuromo bioavailable inhibitor ye fibroblast growth factor receptor (FGFR) ine inogona kuita antineoplastic chiitiko. FGFR inhibitor TAS-120 yakasarudzwa uye isingachinjiki inosunga uye inhibits FGFR, izvo zvingaguma nekudziviswa kwese FGFR-mediated signal transduction nzira uye bundu cell proliferation, uye kuwedzera kwesero kufa muFGFR-overexpressing tumor cells. FGFR ndeye receptor tyrosine kinase yakakosha kune bundu masero kuwanda, kusiyanisa uye kurarama uye kutaura kwayo kunokwidziridzwa mumhando dzakawanda dzebundu cell.
CPDB1093 Derazantinib; ARQ-087 Derazantinib, inozivikanwawo se ARQ-087, ndeyemuromo bioavailable inhibitor ye fibroblast growth factor receptor (FGFR) ine inogona kuita antineoplastic.
CPDB0942 BLU-554 BLU-554 inonzi fibroblast growth factor receptor 4 (FGFR4) inhibitor inogona kurapa hepatocellular carcinoma uye cholangiocarcinoma.
CPD0999 H3B-6527 H3B-6527 (H3 Biomedicine) inosarudza FGFR4 inhibitor ine simba rekurwisa tumour muFGF19 amplified cell lines nemakonzo.
CPD0997 FGF401 FGF-401 inhibitor yeFGFR4 yakatorwa kubva patent WO2015059668A1, muenzaniso wekomboni 83; ine IC50 ye1.9 nM.
CPDB0053 AZD4547 AZD 4547 is selective inhibitor ye fibroblast growth factor receptor (FGFR) tyrosine kinase ine IC50 tsika dze 0.2, 2.5, uye 1.8 nM yeFGFR1, 2, uye 3, zvichienderana.
CPD3610 BLU-9931 BLU9931 ine simba, inosarudza, uye isingadzokeri FGFR4 inhibitor ine IC50 ye3 nM, inenge 297-, 184-, uye 50-fold selectivity pamusoro peFGFR1/2/3, zvichiteerana.
...

Taura nesu

Inquiry

Latest News

  • Pamusoro 7 Trends MuKutsvaga Kwemishonga Muna 2018

    Epamusoro 7 Mafambiro Mukutsvakurudza Kwemishonga Ini...

    Kuve pasi pekumanikidzwa kunoramba kuchiwedzera kukwikwidza munzvimbo yakaoma yehupfumi uye tekinoroji, makambani emishonga uye ebiotech anofanirwa kuramba achivandudza muzvirongwa zvavo zveR&D kuti varambe vari mberi ...

  • ARS-1620: Inovimbisa inhibitor itsva yeKRAS-mutant cancers

    ARS-1620: Inhibitor itsva inovimbisa yeK...

    Zvinoenderana neongororo yakaburitswa muSero, vaongorori vakagadzira chaiyo inhibitor yeKRASG12C inonzi ARS-1602 iyo yakakonzera kudzoka kwebundu mumakonzo. "Chidzidzo ichi chinopa in vivo humbowo hwekuti mutant KRAS inogona ...

  • AstraZeneca inogamuchira kukwidziridzwa kwemishonga yeoncology

    AstraZeneca inogamuchira kukwidziridzwa kwe ...

    AstraZeneca yakagamuchira kukwidziridzwa kwakapetwa kaviri kweiyo oncology portfolio neChipiri, mushure mekunge US neEuropean regulators vabvuma kutumirwa kwemishonga yavo, danho rekutanga rekuhwina mvumo yemishonga iyi. ...

WhatsApp Online Chat !